Urology · New York, NY
NPI
1356303739
Since 2006
Specialty
Urology
Code 208800000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
168 Canal St, Suite 510
New York, NY, 10013
Phone (212) 226-2200
Medicare paid, 2024
$140K
1,198 services
Medicare patients, 2024
201
Average age 77
Drug cost, 2024
$752K
4,302 prescriptions
Company payments, 2025
$911
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Benjamin C Peng was code 99214 (office e&m - established), 327 times for 171 patients. In total Benjamin C Peng billed 1,198 services in 35 codes, and Medicare paid $140K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-11-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 327 | 171 | $106.58 | $35K |
| 76872 Ultrasound - Nonspecific | Office | 118 | 111 | $118.30 | $14K |
| 51741 Test - Miscellaneous | Office | 94 | 87 | $7.41 | $696 |
| 51784 Neurologic | Office | 78 | 74 | $28.48 | $2,221 |
| 99204 Office E&M - New | Office | 71 | 71 | $137.22 | $9,742 |
| 76856 Ultrasound - Abdomen and Pelvis | Office | 71 | 70 | $93.42 | $6,633 |
| 52000 Cystourethroscopy | Office | 60 | 57 | $202.03 | $12K |
| 55899 Other Organ Systems | Office | 43 | 43 | $247.27 | $11K |
| 51797 Other Organ Systems | Office | 33 | 33 | $163.55 | $5,397 |
| 51729 Other Organ Systems | Office | 32 | 32 | $344.01 | $11K |
| 51798 Ultrasound - Nonspecific | Office | 26 | 20 | $9.64 | $251 |
| 52281 Calculus Removal - Urinary | Office | 12 | 12 | $287.85 | $3,454 |
By year: 2022 $167K for 1,467 services; 2023 $150K for 1,374 services; 2024 $140K for 1,198 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81000 Clinical Chemistry | 116 | 111 | $3.94 | $457 |
Medicare prescription drug claims, 2024
In 2024, the drug Benjamin C Peng prescribed most often to Medicare patients was Tamsulosin Hcl, with 887 prescriptions and refills. In total Benjamin C Peng wrote 4,302 Medicare prescriptions that cost $752K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 887 | 2,471 | 351 | $8,007 |
| Finasteride Generic | 881 | 2,462 | 315 | $8,430 |
| Myrbetriq Mirabegron | 518 | 1,191 | 168 | $543K |
| Ciprofloxacin Hcl Generic | 347 | 347 | 276 | $2,095 |
| Silodosin Generic | 238 | 628 | 81 | $29K |
| Desmopressin Acetate Desmopressin (Nonrefrigerated) | 174 | 245 | 69 | $9,713 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 161 | 161 | 101 | $3,204 |
| Potassium Citrate Er Potassium Citrate | 148 | 197 | 52 | $9,470 |
| Bethanechol Chloride Generic | 132 | 247 | 41 | $3,805 |
| Levofloxacin Generic | 113 | 113 | 106 | $443 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 106 | 295 | 44 | $2,495 |
| Dutasteride Generic | 89 | 268 | 34 | $3,360 |
| Valacyclovir Valacyclovir Hcl | 71 | 108 | 22 | $2,514 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 59 | 59 | 21 | $930 |
| Bicalutamide Generic | 42 | 114 | 13 | $1,311 |
Brand drugs: 608 claims; generic drugs: 3,694 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Benjamin C Peng $911 ($911 in general payments such as food, travel and fees) from 10 companies. The largest payer was Janssen Biotech, Inc. with $449.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 10 | $449 |
| Tolmar, Inc. | 4 | $112 |
| Pfizer Inc. PFE | 5 | $110 |
| Verity Pharmaceuticals Inc. | 4 | $75.41 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $46.42 |
| Progenics Pharmaceuticals, Inc. | 1 | $29.18 |
| Olympus America Inc. | 1 | $26.4 |
| Laborie Medical Technologies Corp. | 1 | $24.62 |
| Coloplast Corp | 1 | $21.56 |
| SRS Medical Systems, Inc. | 1 | $16.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.